Advanced Orthomolecular Research AOR Opti-Cholest, 60 Capsules (500 mg per Capsule)
UPC: 624917083798
AOR's Opti-Cholest is a bergamot fruit extract supplement formulated to support healthy cholesterol levels and cardiovascular processes. It uses a proprietary extract called Bergavit, which is noted for a concentrated flavonoid profile, with the dosage per serving matching the amount commonly used in clinical research on bergamot.
This product is distinguished by its focus on a specific, standardized extract rich in polyphenols, which are associated with antioxidant and inflammatory response properties. The manufacturer highlights that the flavonoids in bergamot may help maintain a healthy HDL:LDL ratio. It is produced in a GMP facility and undergoes third-party testing, with certifications for Vegan, Non-GMO, and Gluten-Free status. The capsules are designed to be taken with a meal containing fat for optimal absorption.
At a glance
Supplement Facts
| Ingredient | Amount Per Serving | % Daily Value |
|---|---|---|
| Bergamot fruit extract | 1,000 mg | † |
| † Daily Value not established | ||
Other Ingredients
Capsule (hypromellose), maltodextrin, silicon dioxide, sodium stearyl fumarate.
AOR™ guarantees that all ingredients have been declared on the label. Made without wheat, gluten, nuts, peanuts, sesame seeds, sulfites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Certifications & Claims
Label Information
Directions, warnings, and other information directly from the product label.
Suggested Use
Take 2 capsules daily before a meal containing fat, or as directed by a qualified health care practitioner. Do not crush, mix, or blend capsules. Swallow capsules whole.
Warning
Consult your physician before use if you are pregnant, lactating, have a medical condition, or are taking any medication. Keep out of reach of children.
Product Info
- Brand
- Advanced Orthomolecular Research AOR
- UPC
- 624917083798
- Package Qty
- 60 count
- Dimensions
- 3.8 x 2.05 x 2.05 in
- Shipping Weight
- 0.11 lb
- First Available
- 02/2017





